Oropharyngeal cancer patients with human papillomavirus (HPV) have a more robust response to radiation therapy
UC Davis cancer researchers have discovered significant differences in radiation-therapy response among patients with oropharyngeal cancer depending on whether they carry the human papillomavirus (HPV), a common sexually transmitted virus. The findings could lead to more individualised radiation treatment regimens, which for many patients with HPV could be shorter and potentially less toxic. HPV-related cancers […]
